APA Corporation Announces Retirement of General Counsel Anthony Lannie and Promotion of David J. Bernal to Vice President Legal

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) announces the retirement of executive vice president and general counsel Anthony Lannie, effective Oct. 9, 2024. David J. Bernal has been promoted to vice president Legal and acting general counsel. Mr. Bernal joined APA in 2008 and has handled commercial litigation and counseled executives […]

Uniti Group Inc. to Deliver Keynote Presentation at the 2024 INCOMPAS Show

LITTLE ROCK, Ark., Oct. 15, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, is scheduled to deliver the keynote presentation at the 2024 INCOMPAS Show. The presentation is scheduled for 8:45 AM MDT / 10:45 AM EDT on October 21, 2024 in

Metcal Introduces New MicroFine Products for Soldering Under the Microscope

Metcal, part of OK Internationaland Dover(NYSE: DOV) and a leader in benchtop soldering for electronics and industrial manufacturing, today announced the launch of its newMicroFine™ soldering handpieces and cartridge tips for use under microscopes. https://mma.prnewswire.com/media/717019/Dover_blue_Logo.jpg MicroFine will be offered with both a soldering and tweezer handpiece configuration, compatible with the Metcal MX Series and Connection

Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024

Kintara Therapeutics, Inc. (“Kintara”) (NASDAQ: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced a correction to the press release previously issued by Kintara on October 14, 2024, regarding a record date for the issuance of the Contingent Value Rights (“CVRs”) to stockholders of Kintara pursuant to the

Fetch Announces Strategic Expansion With Strong Financial Outlook Driving Innovation, Operations

With new product launches and growing profitability, Fetch is set to transform the multifamily housing industry, serving 25 markets with additional markets planned for 2025. Fetch, the leader in offsite package management for apartment communities, announced today significant expansion plans and new product launches ahead of the National Multifamily Housing Council’s (NMHC) 2024 OPTECH Conference

Nisun International Reports Financial Results for the First Half of 2024

Company Reports 52% Revenue Growth, Initiates $15 Million Share Buyback Program Nisun International Enterprise Development Group Co., Ltd. (“Nisun International” or the “Company”) (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions provider, today announced its reviewed but unaudited financial results for the six months ended June 30, 2024. First Half 2024 Financial

ASHFORD HOSPITALITY TRUST ANNOUNCES DETAILS FOR REVERSE STOCK SPLIT

Ashford Hospitality Trust, Inc. (NYSE: AHT) (“Ashford Trust” or the “Company”) announced today that its Board of Directors unanimously approved a reverse split of the Company’s common stock at a ratio of 1-for-10. As of the effective date of the reverse split, each share of the Company’s issued and outstanding common stock and equivalents will

Titan to launch VPO™ Technology at Equip Expo 2024

VPO offers a high-performing, durable alternative to tweel wheels Titan International Inc. (Titan) and the recently acquired Carlstar Group are proud to announce the launch of its Variable Pressure Operation (VPO™) Technology™ at Equip Exposition, from October 15-18 in Louisville, Kentucky. This innovative flat-proof technology offers a versatile solution as an alternative to tweel wheels,

PharmAust affirms corporate strategy with name change to Neurizon Therapeutics

Neurizon Therapeutics Limited(ASX: NUZ) (“Neurizon” or “the Company”), a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to announce it has officially changed its name from PharmAust Limited, to Neurizon Therapeutics Limited. The name change was approved by shareholders at the Company’s Annual General Meeting held on 9 October 2024. The

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced the closing of its upsized initial public offering of 17,250,000 shares of its common stock at a public offering price of $17.00 per

Scroll to Top